These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 35039221)
1. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. Dutta S; Mukherjee A; Nongthomba U Cytokine Growth Factor Rev; 2022 Feb; 63():108-118. PubMed ID: 35039221 [TBL] [Abstract][Full Text] [Related]
2. Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells. Salina ACG; Dos-Santos D; Rodrigues TS; Fortes-Rocha M; Freitas-Filho EG; Alzamora-Terrel DL; Castro IMS; Fraga da Silva TFC; de Lima MHF; Nascimento DC; Silva CM; Toller-Kawahisa JE; Becerra A; Oliveira S; Caetité DB; Almeida L; Ishimoto AY; Lima TM; Martins RB; Veras F; do Amaral NB; Giannini MC; Bonjorno LP; Lopes MIF; Benatti MN; Batah SS; Santana RC; Vilar FC; Martins MA; Assad RL; de Almeida SCL; de Oliveira FR; Arruda Neto E; Cunha TM; Alves-Filho JC; Bonato VLD; Cunha FQ; Fabro AT; Nakaya HI; Zamboni DS; Louzada-Junior P; Oliveira RDR; Cunha LD Elife; 2022 Jun; 11():. PubMed ID: 35666101 [TBL] [Abstract][Full Text] [Related]
3. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
4. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158 [TBL] [Abstract][Full Text] [Related]
5. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. Silberberg E; Filep JG; Ariel A Front Immunol; 2022; 13():863449. PubMed ID: 35615359 [TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748 [TBL] [Abstract][Full Text] [Related]
8. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Quirch M; Lee J; Rehman S J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and cancer: start the resolution! Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921 [TBL] [Abstract][Full Text] [Related]
10. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828 [TBL] [Abstract][Full Text] [Related]
12. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P Front Immunol; 2021; 12():589095. PubMed ID: 33995341 [TBL] [Abstract][Full Text] [Related]
13. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review. Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187 [TBL] [Abstract][Full Text] [Related]
14. Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2. Ng WH; Tang PCH; Mahalingam S; Liu X Br J Pharmacol; 2023 Jan; 180(2):133-143. PubMed ID: 36394425 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies. Chong ZZ; Souayah N Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839 [TBL] [Abstract][Full Text] [Related]
16. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection. Ahmed F Front Immunol; 2020; 11():590459. PubMed ID: 33362771 [TBL] [Abstract][Full Text] [Related]
17. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. Ali FEM; Mohammedsaleh ZM; Ali MM; Ghogar OM World J Gastroenterol; 2021 Apr; 27(15):1531-1552. PubMed ID: 33958841 [TBL] [Abstract][Full Text] [Related]
18. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025 [TBL] [Abstract][Full Text] [Related]
19. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE Front Immunol; 2021; 12():749291. PubMed ID: 34867978 [TBL] [Abstract][Full Text] [Related]
20. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm. Mahmoud IS; Jarrar YB; Febrimarsa Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]